ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Mersana Therapeutics Inc

Mersana Therapeutics Inc (MRSN)

0.582
-0.0273
(-4.48%)
Closed February 17 3:00PM
0.589
0.007
(1.20%)
After Hours: 6:47PM

Mersana Therapeutics Inc Financial Summary

The current MRSN market cap is 72.76M. The company's latest EPS is USD -1.3894 and P/E is -0.42.

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 7.7M10.7M9.25M2.29M12.6M
Operating Income -43.94M-21.39M-21M-25.46M-12.07M
Net Income -41.66M-19.51M-19.31M-24.27M-11.5M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 42.12M828k43k26.58M36.86M
Operating Income -30.2M-88.11M-168.86M-203.77M-179.64M
Net Income -28.21M-88.05M-170.06M-204.21M-171.64M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 262.9M226.06M198.37M179.13M169.53M
Total Liabilities 210.71M189.16M170.39M170.7M168.48M
Total Equity 52.2M36.9M27.99M8.43M1.05M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 107.54M273.4M206.11M334.34M226.06M
Total Liabilities 29.22M45.31M84.37M242.28M189.16M
Total Equity 78.32M228.09M121.74M92.06M36.9M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -136.92M-168.88M-32.66M-63.11M-63.09M
Investing 99.74M119.88M-72.55M-67.03M-38.56M
Financing 94.58M94.68M5.83M6.24M5.96M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -67.74M-74.7M-139.99M-49.36M-168.88M
Investing -27.29M37.03M-648k-152.72M119.88M
Financing 97.7M230.41M63.65M153.02M94.68M
Market Cap 72.76M
Price to Earnings Ratio -0.42
Price to Sales Ratio 1.98
Price to Cash Ratio 0.42
Price to Book Ratio 1.97
Dividend Yield -

Share Statistics

Shares Outstanding 123.53M
Average Volume (1 week) 3.36M
Average Volume (1 Month) 6.23M
52 Week Change -85.01%
52 Week High 6.2801
52 Week Low 0.5189
Spread (Intraday) 0.01 (1.08%)

Company Info

Company Name Mersana Therapeutics Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.mersana.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock